Showing results (71-80 of 1,069) with videos related to

Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|April 7, 2018
Defining distinct features of anti-MOG antibody associated central nervous system demyelinationMartin S Weber, Tobias Derfuss, Imke Metz, et al.
Therapeutic Advances in Neurological Disorders|July 7, 2018
MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the artGiovanna Stefania Colafati, Ioan Paul Voicu, Chiara Carducci, et al.
Therapeutic Advances in Neurological Disorders|August 22, 2020
Wernicke-Korsakoff syndrome associated with mtDNA diseaseIdris Janos Jimoh, Barbara Sebe, Peter Balicza, et al.
Therapeutic Advances in Neurological Disorders|March 31, 2021
Endovascular therapy in patients with large vessel occlusion due to cardioembolism versus large-artery atherosclerosisMeredeth Zotter, Eike I Piechowiak, Rupashani Balasubramaniam, et al.
Therapeutic Advances in Neurological Disorders|April 2, 2021
Expanding indications for endovascular thrombectomy-how to leave no patient behindPeter B Sporns, Jens Fiehler, Johanna Ospel, et al.
Therapeutic Advances in Neurological Disorders|April 2, 2021
Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progressionSamantha A Banks, Elia Sechi, Eoin P Flanagan
Therapeutic Advances in Neurological Disorders|April 2, 2021
Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world studyTil Menge, Karin Rehberg-Weber, Kirsi Taipale, et al.
Therapeutic Advances in Neurological Disorders|April 2, 2021
Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillanceHiroyuki Murai, Shigeaki Suzuki, Miki Hasebe, et al.
Therapeutic Advances in Neurological Disorders|July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practicePer Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Pageof 107